Please use this identifier to cite or link to this item: http://pucir.inflibnet.ac.in:8080/jspui/handle/123456789/734
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPasupuleti, Samba Siva Rao-
dc.date.accessioned2024-06-14T09:13:35Z-
dc.date.available2024-06-14T09:13:35Z-
dc.date.issued2022-
dc.identifier.urihttp://pucir.inflibnet.ac.in:8080/jspui/handle/123456789/734-
dc.description.abstractBackground: Cytomegalovirus (CMV) reactivation is known to occur among intensive care unit (ICU) patients. CMV-reactivation is not well-evaluated among critically ill cirrhotic adults who are not overtly immunocompro- mised. Objectives: Primary objective was to estimate the CMV-reactivation incidence rate among seropositive/latently infected critically ill cirrhotic adults. The secondary objective was to study the risk factors, host-related cytokine responses, and ICU outcomes associated with CMV-reactivation . Methods: In this longitudinal study conducted between November 2018 and June 2019, all consecutive anti- CMV-IgG-positive cirrhotic Liver-ICU patients were assessed at day 0/ICU-admission, day 7, 14, and 21 for CMV- reactivation/plasma-DNAemia ( ≥ 500 IU/ml), cytokines, clinical, laboratory and outcome parameters. Results: Fifty-five (48 male) cirrhosis patients consecutively admitted to liver-ICU were prospectively studied. Twenty (36%) adults developed CMV-reactivation. Majority (n = 17/55, 30.9%; 95% CI: 19.1 - 44.8) showed CMV- reactivation on ICU-day 7. CMV-reactivation incidence rate during 21-day follow-up was 2.75% per person-day (95% CI: 1.68-4.26% per person-day). None of the risk factors studied was independently associated with CMV- reactivation. Acute respiratory distress syndrome (p = 0.04), systemic inflammatory response syndrome (p = 0.01), secondary (bacterial and/or fungal) infections (p = 0.009), and raised pro-inflammatory cytokines (IFN 𝛾, p = 0.012; TNF 𝛼, p = 0.052) were observed concomitantly to CMV-reactivation on ICU-day 7. ICU-Mortality (n = 34/55, 61.8%) did not vary with a presence or absence of CMV-reactivation (55% versus 65.7%; p = 0.43). Length of stay (LOS) in liver-ICU did not differ concerning CMV-reactivation (5 days versus 4.5 days; p = 0.17) Conclusions: CMV-reactivation incidence rate was considerable among seropositive non-immunosuppressed crit- ically ill cirrhotic adults. Mortality and LOS in Liver-ICU were not significantly influenced by CMV-reactivation.en_US
dc.language.isoen_USen_US
dc.subjectKeywords: Cytomegalovirus Reactivation ICU Cirrhosis Real-Time PCR Critically illen_US
dc.titleCytomegalovirus reactivation in seropositive critically ill patients with liver cirrhosis: A hospital-based longitudinal studyen_US
dc.typeOtheren_US
Appears in Collections:Journal

Files in This Item:
File Description SizeFormat 
1-s2.0-S2667038022000266-main.pdf1.38 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.